The following would suggest that testing for CH before T-cell therapy is undertaken is part of the answer.
Also, the fact that the incidence of cancer increases with age, suggests that CH could be more prevalent in older people. And, we already know that the first iterations of any new technology such as Car-T are "clunky" and that combination therapies are also the answer.
https://ashpublications.org/blood/article/130/6/742/36791/Clonal-hematopoiesis-with-and-without-candidate
I reckon rejuvenating stem cells the same way that our CellPryme makes the immune cells' phenotype younger could be one way to go to combat this issue the CH issue!
Whether CellPryme (news) will solve my age-related issues after all this time is another matter. Time will tell... but I wish FGS that Steve would tell!
- Forums
- ASX - By Stock
- PTX
- PTX Media related
PTX Media related, page-1600
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
-0.005(10.6%) |
Mkt cap ! $33.82M |
Open | High | Low | Value | Volume |
4.7¢ | 4.7¢ | 4.2¢ | $81.21K | 1.844M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11932 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11932 | 0.042 |
3 | 544492 | 0.041 |
8 | 697543 | 0.040 |
4 | 720000 | 0.039 |
3 | 851052 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 50000 | 1 |
0.044 | 47944 | 2 |
0.045 | 22000 | 1 |
0.047 | 21285 | 2 |
0.049 | 209694 | 3 |
Last trade - 15.57pm 26/08/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |